Literature DB >> 9484416

Diagnostic aspects of narcolepsy.

M S Aldrich1.   

Abstract

The diagnostic criteria for narcolepsy continue to evolve as more is learned about the features of this and other sleep disorders. A variety of symptoms have been said to distinguish narcolepsy from other sleep disorders, including cataplexy, character of daytime sleepiness, sleep paralysis, hypnagogic hallucinations, and automatic behavior. Other diagnostic assessments, such as determination of human leukocyte antigen (HLA) haplotype and findings of sleep laboratory assessments, also contribute to the differential diagnosis. As diagnostic and analytic techniques have become more sophisticated, however, it has become apparent that many of the characteristic features of narcolepsy--including the HLA-DR2 haplotype, sleep-onset REM sleep, and short sleep latency--may also be present in other sleep disorders. Although unambiguous cataplexy does not occur with other sleep disorders and is therefore a valuable symptom for diagnosis, it may occur with a few other neurologic disorders. Furthermore, the clinical assessment of cataplexy-like symptoms is not always straightforward. Current evidence suggests there is a fairly well-defined syndrome of narcolepsy-cataplexy that is highly associated with specific HLA markers and REM sleep abnormalities. On the other hand, there is substantial clinical overlap between narcolepsy without cataplexy and idiopathic hypersomnia. Patients with features of narcolepsy who do not have definite cataplexy and patients with features of idiopathic hypersomnia must be assessed thoroughly because of the possibility that other sleep disorders are the cause of the symptoms.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9484416     DOI: 10.1212/wnl.50.2_suppl_1.s2

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  17 in total

1.  Lesson of the week: Narcolepsy mistaken for epilepsy.

Authors:  A Zeman; N Douglas; R Aylward
Journal:  BMJ       Date:  2001-01-27

2.  The injection of hypocretin-1 into the nucleus pontis oralis induces either active sleep or wakefulness depending on the behavioral state when it is administered.

Authors:  Mingchu Xi; Michael H Chase
Journal:  Sleep       Date:  2010-09       Impact factor: 5.849

3.  Visual hallucinations: differential diagnosis and treatment.

Authors:  Ryan C Teeple; Jason P Caplan; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

4.  HLA-DQ polymorphism influences progression of demyelination and neurologic deficits in a viral model of multiple sclerosis.

Authors:  K D Pavelko; K M Drescher; D B McGavern; C S David; M Rodriguez
Journal:  Mol Cell Neurosci       Date:  2000-06       Impact factor: 4.314

Review 5.  Genetic association, seasonal infections and autoimmune basis of narcolepsy.

Authors:  Abinav Kumar Singh; Josh Mahlios; Emmanuel Mignot
Journal:  J Autoimmun       Date:  2013-03-13       Impact factor: 7.094

6.  Activity of dorsal raphe cells across the sleep-waking cycle and during cataplexy in narcoleptic dogs.

Authors:  M-F Wu; J John; L N Boehmer; D Yau; G B Nguyen; J M Siegel
Journal:  J Physiol       Date:  2004-01-01       Impact factor: 5.182

Review 7.  Narcolepsy in the older adult: epidemiology, diagnosis and management.

Authors:  Sangeeta S Chakravorty; David B Rye
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

8.  Developmental changes in CSF hypocretin-1 (orexin-A) levels in normal and genetically narcoleptic Doberman pinschers.

Authors:  Joshi John; Ming-Fung Wu; Nigel T Maidment; Hoa A Lam; Lisa N Boehmer; Melanie Patton; Jerome M Siegel
Journal:  J Physiol       Date:  2004-08-12       Impact factor: 5.182

9.  Can transcranial magnetic stimulation be used to evaluate patients with narcolepsy?

Authors:  Anupa A Vijayakumari; Fayaz R Khan; Ravi Prasad Varma; Ashalatha Radhakrishnan
Journal:  Neurol Sci       Date:  2012-11-29       Impact factor: 3.307

Review 10.  Hypocretin (orexin): role in normal behavior and neuropathology.

Authors:  Jerome M Siegel
Journal:  Annu Rev Psychol       Date:  2004       Impact factor: 24.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.